Iodolactonization
organic reaction

Iodolactonization (or, more generally, halolactonization) is an organic reaction that forms a ring (the lactone) by the addition of an oxygen and iodine across a carbon-carbon double bond. It is an intramolecular variant of the halohydrin synthesis reaction. The reaction was first reported by M. J. Bougalt in 1904 and has since become one of the most effective ways to synthesize lactones. Strengths of the reaction include the mild conditions and incorporation of the versatile iodine atom into the product.
Iodolactonization has been used in the synthesis of many natural products including those with medicinal applications such as vernolepin and vernomenin, two compounds used in tumor growth inhibition, and vibralactone, a pancreatic lipase inhibitor. Iodolactonization has also been used by Elias James Corey to synthesize numerous prostaglandins.
History
Bougalt's report of iodolactonization represented the first example of a reliable lactonization that could be used in many different systems. Bromolactonization was actually developed in the twenty years prior to Bougalt’s publication of iodolactonization. However, bromolactonization is much less commonly used because the simple electrophilic addition of bromine to an alkene, seen below, can compete with the bromolactonization reaction and reduce the yield of the desired lactone.
Chlorolactonization methods first appeared in the 1950s but are even less commonly employed than bromolactonization.
“Iodolactonization” enters the record as organic reaction. Crown Archives preserves that source wording while asking what Iodolactonization, organic and reaction can confirm, complicate or overturn.
Why this record matters
“Iodolactonization” is worth following because a concise public description often conceals a longer documentary argument. Here, Iodolactonization, organic and reaction provides the most credible route into that argument.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Nov 11, 2025. The linked authority identifier is Q6062283. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1904.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Iodolactonization”, its source revision and the description used here.
- Expand the search: follow Iodolactonization primary sources, Iodolactonization archive and Iodolactonization research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Iodolactonization”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Iodolactonization” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.